ADMA

PSR 5배 정도

목표주가 평균 8

면역 폐렴

ADMA Biologics, Inc.

Discover ADMA Biologics Patented Immunotechnology* Designed for the Immunocompromised We manufacture, develop and commercialize specialized, targeted, plasma-derived therapeutics to extend and enhance the lives of individuals who are naturally or medically

www.admabiologics.com

ADMA Corporate Deck 11092020.pdf

9.86MB

728x90

'---매수대상--- > 미국 스몰캡 주당 10불 이하' 카테고리의 다른 글

TXMD (0)	2021.02.01
GLMD GALMED PHARMACEUTICALS 갈메드 (0)	2021.01.29
LIFE ATVR PHARMA (0)	2021.01.29
ATPO 압토즈 바이오 (0)	2020.12.11
PROG 여성 치료 전용 바이오 (0)	2020.12.10